Showing results (11-20 of 2,280) with videos related to

Sort By:
Pageof 228
HIV Medicine|October 11, 2021
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study)Jennifer A Brown, Bienvenu L Nsakala, Kuena Mokhele, et al.
HIV Medicine|October 11, 2021
Impact of coronavirus disease (COVID-19) on HIV testing and care provision across four continentsFernanda Rick, Wilfred Odoke, Jan van den Hombergh, et al.
HIV Medicine|October 11, 2021
No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adultsJames E Burns, Oliver Stirrup, Laura Waters, et al.
HIV Medicine|October 11, 2021
Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross-sectional and longitudinal analysesTimothy P W Jones, Fiona C Lampe, Alejandro Arenas-Pinto, et al.
HIV Medicine|April 7, 2022
Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population-based cohort studyEllen Moseholm, Terese Lea Katzenstein, Gitte Pedersen, et al.
HIV Medicine|May 26, 2010
Screening for 'window-period' acute HIV infection among pregnant women in rural South AfricaA B M Kharsany, N Hancock, J A Frohlich, et al.
HIV Medicine|October 20, 2010
Cohort profile: the German ClinSurv HIV project--a multicentre open clinical cohort study supplementing national HIV surveillanceJ Bätzing-Feigenbaum, C Kollan, A Kühne, et al.
HIV Medicine|October 20, 2010
Trends over time of virological and immunological characteristics in the Swiss HIV Cohort StudyB Ledergerber, M Cavassini, M Battegay, et al.
HIV Medicine|August 25, 2010
Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study)M Zazzi, R Kaiser, A Sönnerborg, et al.
HIV Medicine|November 10, 2010
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohortA M Cescon, C Cooper, K Chan, et al.
Pageof 228